[AVDL] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -140.10%
YoY- -224.01%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 41,504 1,496 0 0 10,091 17,554 29,230 6.01%
PBT -14,331 -64,342 -33,251 -23,346 36,166 -6,824 -3,780 24.84%
Tax -509 90 30,193 -3,765 5,292 1,781 -342 6.84%
NP -13,822 -64,432 -63,444 -19,581 30,874 -8,605 -3,438 26.07%
Tax Rate - - - - -14.63% - - -
Total Cost 55,326 65,928 63,444 19,581 -20,783 26,159 32,668 9.16%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -33.30 -4,306.95 0.00 0.00 305.96 -49.02 -11.76 18.92%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.14 -0.83 -1.07 -0.33 0.57 -0.23 -0.09 7.63%
EPS Diluted -0.14 -0.83 -1.07 -0.33 0.49 -0.23 -0.09 7.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.